glycidyl nitrate has been researched along with Crohn Disease in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.63) | 18.7374 |
1990's | 6 (15.79) | 18.2507 |
2000's | 19 (50.00) | 29.6817 |
2010's | 10 (26.32) | 24.3611 |
2020's | 2 (5.26) | 2.80 |
Authors | Studies |
---|---|
Fu, J; Gao, J; He, X; Hu, M; Hu, S; Huang, Z; Jin, S; Lu, B; Sun, K; Wang, Z; Weersma, RK; Zhao, X; Zhou, H | 1 |
Chassaing, B | 1 |
Keestra-Gounder, AM; Tsolis, RM | 1 |
Jing, Y; Ran, Y; Wang, BM; Zhao, J; Zhou, L; Zhou, Z | 1 |
Jing, Y; Lv, Z; Qian, Y; Ran, Y; Wang, B; Yin, Z; Zhang, J; Zhang, M; Zhao, J; Zhou, L; Zhou, Z | 1 |
Bonnefond, A; Dhennin, V; Frade-Proud'Hon-Clerc, S; Frenois, F; Froguel, P; Fumery, M; Gower-Rousseau, C; Guillon-Dellac, N; Sand, O; Smol, T; Vaillant, E; Vasseur, F | 1 |
Adler, J; Bender, D; Owens, SR; Rahal, K; Reingold, L; Rittershaus, AC; Schmiedlin-Ren, P; Zimmermann, EM | 1 |
Qin, X | 1 |
Brynjolfsson, SF; Håkansson, K; Jensen, T; Jo Wick, M; Kong, PL; Kuijper, JL; Magnusson, MK; Read, CB; Sjövall, H; Stennicke, VW | 1 |
Fritz, JH; Girardin, SE; Gommerman, JL; Le Bourhis, L; Magalhaes, JG; Philpott, DJ; Sellge, G; Selvanantham, T; Travassos, LH | 1 |
Hewitt, RE; Metz, A; Parkes, M; Pele, LC; Powell, JJ; Tremelling, M | 1 |
Adler, J; Christman, GM; Dhanani, M; McKenna, BJ; Rahal, K; Reingold, L; Rittershaus, AC; Schmiedlin-Ren, P; Sultani, V; Zhu, J; Zimmermann, EM | 1 |
Nielsen, OH; Rogler, G; Salem, M; Seidelin, JB | 1 |
Bonen, DK; Brant, SR; Chen, FF; Cho, JH; Duerr, RH; Foster, SJ; Inohara, N; Nicolae, DL; Nuñez, G; Ogura, Y; Saab, L; Tanabe, T | 1 |
Crespo, J; Fernandez-Luna, JL; Fontalba, A; Foster, SJ; Fukase, K; Gutierrez, O; Hashimoto, M; Inamura, S; Inohara, N; Kusumoto, S; Moran, AP; Nuñez, G; Ogura, Y; Pons, F | 1 |
Boneca, IG; Chamaillard, M; Girardin, SE; Labigne, A; Philpott, DJ; Sansonetti, PJ; Thomas, G; Viala, J | 1 |
Bui, TH; Chamaillard, M; Chareyre, F; Giovannini, M; Girardin, SE; Hugot, JP; Lesage, S; Penard-Lacronique, V; Philpott, D; Sansonetti, PJ; Thomas, G; Zaehringer, U; Zouali, H | 1 |
Girardin, SE; Hugot, JP; Sansonetti, PJ | 1 |
de Jong, DJ; Drenth, JP; Franke, B; Kullberg, BJ; Naber, TH; Netea, MG; Sprong, T; Van der Meer, JW | 1 |
Bankston, LA; Eckmann, L; Hsu, LC; Iimura, M; Kagnoff, MF; Karin, M; Liu, H; Maeda, S | 1 |
Adema, GJ; de Jong, DJ; Drenth, JP; Ferwerda, G; Girardin, SE; Jacobs, L; Jansen, T; Kramer, M; Kullberg, BJ; Naber, TH; Netea, MG; Van der Meer, JW | 1 |
Kambe, N; Kanazawa, N; Nishikomori, R | 1 |
Boneca, IG; de Jong, DJ; Dharancy, S; Ferwerda, G; Girardin, SE; Jéhanno, M; Mengin-Lecreulx, D; Netea, MG; Philpott, DJ; Sansonetti, PJ; Van Der Meer, JW; Werts, C | 1 |
de Jong, DJ; Ferwerda, G; Girardin, SE; Kullberg, BJ; Netea, MG; van der Meer, JW | 1 |
Harder, J; Schröder, JM; Stange, EF; Voss, E; Wehkamp, J; Wehkamp, K | 1 |
Ghosh, S; Hervé, M; Hunt, KA; Playford, RJ; van Heel, DA | 1 |
Strober, W | 1 |
Banks, DJ; Kufer, TA; Philpott, DJ | 1 |
de Jong, DJ; Drenth, JP; Ferwerda, G; Joosten, LA; Kullberg, BJ; Netea, MG; Van der Meer, JW | 1 |
Benko, S; Girardin, SE; Le Bourhis, L | 1 |
de Visser, H; Hazenberg, MP; Hoke, G; Hooijkaas, H; Klasen, IS; Melief, MJ; Schouten, WR; van Blankenstein, M; van Halteren, AG | 1 |
Grisham, MB; Marshall, S; Sartor, RB; Specian, RD; Yamada, T | 1 |
Fukumura, D; Ishii, H; Kimura, H; Kurose, I; Miura, S; Mori, M; Ohkubo, N; Serizawa, H; Tanaka, S; Tsuzuki, Y | 1 |
Brand, S; Conner, EM; Davis, JM; Fuseler, JW; Grisham, MB; Kang, DY; Laroux, FS; Palombella, VJ; Wolf, RE | 1 |
Binnema, DJ; Hazenberg, MP; Ruseler-van Embden, JG; Van Lieshout, LM | 1 |
Hokari, R; Iizuka, T; Ishii, H; Itoh, K; Iwai, A; Kato, S; Kawaguchi, A; Matsuzaki, K; Miura, S; Miyahara, T; Miyasaka, M; Nagao, S; Nagata, H; Sekizuka, E | 1 |
Bras, MJ; de Visser, H; Hazenberg, MP; Prins, ME; van de Merwe, JP | 1 |
Hazenberg, MP; Pennock-Schröder, AM; Van de Merwe, JP; Wensinck, F | 1 |
6 review(s) available for glycidyl nitrate and Crohn Disease
Article | Year |
---|---|
NOD1 and NOD2: Beyond Peptidoglycan Sensing.
Topics: Animals; Crohn Disease; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Humans; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Obesity; Parasites; Peptidoglycan; Signal Transduction; Viruses | 2017 |
Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Autophagy; Biological Transport; Crohn Disease; Humans; Immune System; Inflammation; Nod2 Signaling Adaptor Protein; Paneth Cells; Peptidoglycan; Protein Structure, Tertiary; Signal Transduction; T-Lymphocytes; Toll-Like Receptors | 2013 |
Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing.
Topics: Animals; Bacterial Infections; Carrier Proteins; Crohn Disease; Genetic Predisposition to Disease; Humans; Intracellular Signaling Peptides and Proteins; Nod2 Signaling Adaptor Protein; Peptidoglycan | 2003 |
The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders.
Topics: Arthritis; Cell Wall; Crohn Disease; Cytosol; Genetic Diseases, Inborn; Granuloma; Humans; Immune System; Inflammation; Intracellular Signaling Peptides and Proteins; Models, Biological; Monocytes; Mutation; Mutation, Missense; Nod2 Signaling Adaptor Protein; Peptidoglycan; Protein Structure, Tertiary; Sarcoidosis; Skin; Syndrome; Uveitis | 2005 |
Innate immune sensing of microbes by Nod proteins.
Topics: Adaptor Proteins, Signal Transducing; Animals; Crohn Disease; Frameshift Mutation; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Immunity, Innate; Inflammation; Intracellular Signaling Peptides and Proteins; Mice; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Peptidoglycan | 2006 |
Nod1 and Nod2 in innate immunity and human inflammatory disorders.
Topics: Bacteria; Crohn Disease; Genetic Predisposition to Disease; Humans; Immunity, Innate; Mutation; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Peptidoglycan; Sarcoidosis; Signal Transduction; Syndrome | 2007 |
32 other study(ies) available for glycidyl nitrate and Crohn Disease
Article | Year |
---|---|
Gut microbial DL-endopeptidase alleviates Crohn's disease via the NOD2 pathway.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Colitis; Crohn Disease; Endopeptidases; Gastrointestinal Microbiome; Ligands; Mice; Nod2 Signaling Adaptor Protein; Peptidoglycan | 2022 |
When NOD ligands become antidotes.
Topics: Antidotes; Crohn Disease; Genetic Predisposition to Disease; Humans; Inflammation; Ligands; Mutation; Nod2 Signaling Adaptor Protein; Peptidoglycan | 2022 |
[Role of Rac1 signaling pathway of azathioprine and peptidoglycan in the regulation of monocyte-macrophage apoptosis in Crohn's disease].
Topics: Apoptosis; Azathioprine; Case-Control Studies; Crohn Disease; Humans; Inflammation; Intestinal Mucosa; Leukocytes, Mononuclear; Macrophages; Monocytes; Peptidoglycan; rac1 GTP-Binding Protein; Signal Transduction; Thioguanine | 2018 |
Peptidoglycan Suppresses Phagocytic Activities and Apoptosis of Macrophages in Colonic Mucosa Tissues of Crohn's Disease Patients and In Vitro.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apoptosis; Biopsy; Crohn Disease; Humans; Inflammation; Intestinal Mucosa; Leukocytes, Mononuclear; Macrophages; Peptidoglycan; Phagocytosis; rac1 GTP-Binding Protein; Signal Transduction; Up-Regulation; Young Adult | 2018 |
A Novel Rare Missense Variation of the
Topics: Adolescent; Adult; Alleles; Child; Crohn Disease; Exome Sequencing; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Immunity, Innate; Male; Mutation; Mutation, Missense; Nod2 Signaling Adaptor Protein; Peptidoglycan; Polymorphism, Single Nucleotide; Protein Conformation | 2019 |
Development of a peptidoglycan-polysaccharide murine model of Crohn's disease: effect of genetic background.
Topics: Animals; Cecum; Colitis; Crohn Disease; Disease Models, Animal; Fibrosis; Humans; Ileitis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Nod2 Signaling Adaptor Protein; Peptidoglycan; Peyer's Patches; Rats; Receptor-Interacting Protein Serine-Threonine Kinase 2; Receptor-Interacting Protein Serine-Threonine Kinases | 2013 |
How NOD2 and autophagy may be related to Crohn's disease? A view shifted from live microbes to luminal bacterial debris.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Autophagy; Crohn Disease; Humans; Lipopolysaccharides; Nod2 Signaling Adaptor Protein; Peptidoglycan | 2014 |
An Antibody Against Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Dampens Proinflammatory Cytokine Secretion by Lamina Propria Cells from Patients with IBD.
Topics: Adult; Aged; Antibodies; Biomarkers; Case-Control Studies; Cells, Cultured; Colitis, Ulcerative; Crohn Disease; Cytokines; Female; Humans; Interleukin-1beta; Interleukin-8; Intestinal Mucosa; Macrophages; Male; Middle Aged; Neutrophils; Peptidoglycan; Peroxidase; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
Nod2-dependent Th2 polarization of antigen-specific immunity.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Antigens, Bacterial; Crohn Disease; Immunoglobulin G; Inflammation; Interleukin-4; Interleukin-5; Intestinal Mucosa; Mice; Nod2 Signaling Adaptor Protein; Peptidoglycan; Signal Transduction; Th1 Cells; Th2 Cells; Toll-Like Receptors | 2008 |
Immuno-inhibitory PD-L1 can be induced by a peptidoglycan/NOD2 mediated pathway in primary monocytic cells and is deficient in Crohn's patients with homozygous NOD2 mutations.
Topics: B7-H1 Antigen; Crohn Disease; Escherichia coli; Female; Gene Expression; Humans; Lipopolysaccharides; Male; Monocytes; Mutation; Nod2 Signaling Adaptor Protein; Peptidoglycan; Staphylococcus aureus | 2012 |
Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Crohn Disease; Cytokines; Disease Models, Animal; Female; Fibrosis; Ileum; Peptidoglycan; Polysaccharides; Procollagen; Rats; Rats, Inbred Lew; Resveratrol; Serum Albumin; Stilbenes | 2012 |
Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
Topics: Alleles; Carrier Proteins; Case-Control Studies; Cell Line; Crohn Disease; Frameshift Mutation; Genetic Predisposition to Disease; Genetic Variation; Genotype; Heterozygote; Humans; Intracellular Signaling Peptides and Proteins; Jews; Lipopolysaccharides; Nod2 Signaling Adaptor Protein; Peptidoglycan; Signal Transduction | 2003 |
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Bacillus subtilis; Carrier Proteins; Cell Line; Crohn Disease; Escherichia coli; Genetic Predisposition to Disease; Humans; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Mutagenesis, Site-Directed; NF-kappa B; Nod2 Signaling Adaptor Protein; Peptidoglycan; Recombinant Proteins; Substrate Specificity; Transfection | 2003 |
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Amino Acid Motifs; Animals; Carrier Proteins; Cell Line; Crohn Disease; Escherichia coli; Frameshift Mutation; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Microscopy, Fluorescence; NF-kappa B; Nod2 Signaling Adaptor Protein; Peptidoglycan; Plasmids; Protein Structure, Tertiary; Shigella flexneri; Staphylococcus aureus; Transfection | 2003 |
Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.
Topics: Alleles; Bacteria; Carrier Proteins; Cell Line; Crohn Disease; Genetic Variation; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; NF-kappa B; Nod2 Signaling Adaptor Protein; Peptidoglycan; Phenotype | 2003 |
NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Topics: Animals; Bacteroides; Carrier Proteins; Cells, Cultured; CHO Cells; Cricetinae; Crohn Disease; Cytokines; Genotype; Humans; Inflammation Mediators; Interleukin-10; Intracellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Ligands; Lipopolysaccharides; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Nod2 Signaling Adaptor Protein; Peptidoglycan; Polymorphism, Genetic; Receptors, Cell Surface; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2004 |
Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Anti-Bacterial Agents; Apoptosis; Bacteria; Cells, Cultured; Colitis; Colon; Crohn Disease; Cytokines; Dextran Sulfate; Interleukin-1; Intestinal Mucosa; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Mutation; NF-kappa B; Nod2 Signaling Adaptor Protein; Peptidoglycan; Signal Transduction | 2005 |
Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Cells, Cultured; Crohn Disease; Cysteine; Cytokines; Drug Synergism; Humans; Intracellular Signaling Peptides and Proteins; Lipopeptides; Lipoproteins; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mycoplasma; Nod2 Signaling Adaptor Protein; Oligopeptides; Peptidoglycan; Receptors, Cell Surface; Receptors, Immunologic; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 5; Toll-Like Receptor 7; Toll-Like Receptor 9; Toll-Like Receptors | 2005 |
The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adaptor Proteins, Signal Transducing; Amino Acid Motifs; Animals; Cell Line; Crohn Disease; Down-Regulation; Frameshift Mutation; Genotype; Homozygote; Humans; Hydrolysis; Interleukin-10; Intracellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Models, Biological; Models, Chemical; Mutation; NF-kappa B; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Peptides; Peptidoglycan; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Teichoic Acids; Toll-Like Receptors; Transfection | 2005 |
NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Alleles; Case-Control Studies; Crohn Disease; Gene Expression Regulation; Genetic Predisposition to Disease; Homozygote; Humans; Interleukin-1; Intracellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Lipopeptides; Mutation; Nod2 Signaling Adaptor Protein; Oligopeptides; Peptidoglycan; Polymerase Chain Reaction; Signal Transduction; Toll-Like Receptor 2 | 2005 |
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Defensins; Binding Sites; Biotinylation; Cell Line; Crohn Disease; DNA, Complementary; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Frameshift Mutation; Genes, Reporter; Humans; Intracellular Signaling Peptides and Proteins; Keratinocytes; Ligands; Luciferases; Mutagenesis, Site-Directed; Mutation; NF-kappa B; Nod2 Signaling Adaptor Protein; Peptides; Peptidoglycan; Plasmids; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Small Interfering; Sesquiterpenes; Sesquiterpenes, Guaiane; Transcription Factor AP-1; Transfection | 2006 |
Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adaptor Proteins, Signal Transducing; Crohn Disease; Enzyme-Linked Immunosorbent Assay; Genotype; Humans; Interleukin-1; Interleukin-8; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Peptidoglycan; Tumor Necrosis Factor-alpha | 2006 |
Immunology. Unraveling gut inflammation.
Topics: alpha-Defensins; Animals; Antigens, Neoplasm; Bacteria; Biomarkers, Tumor; Crohn Disease; Dendritic Cells; Gastroenteritis; Humans; Immunity, Innate; Immunity, Mucosal; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Lectins, C-Type; Mice; Pancreatitis-Associated Proteins; Paneth Cells; Peptidoglycan; Proteins | 2006 |
Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli.
Topics: Bacteria; Cells, Cultured; Colon; Crohn Disease; Enterocytes; Genetic Predisposition to Disease; Humans; Immune Tolerance; Intestinal Mucosa; Mutation; Nod2 Signaling Adaptor Protein; Peptidoglycan; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2008 |
The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease.
Topics: Adult; Antibodies, Monoclonal; Antigens, Bacterial; Cell Wall; Colon; Crohn Disease; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Peptidoglycan; Polysaccharides; Staining and Labeling; Streptococcus pyogenes | 1994 |
Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats.
Topics: Amino Acid Oxidoreductases; Animals; Chronic Disease; Colitis; Crohn Disease; Disease Models, Animal; Enzyme Induction; Female; Granuloma; Intestinal Mucosa; Nitric Oxide Synthase; Peptidoglycan; Peroxidase; Rats; Rats, Inbred Lew; Streptococcus pyogenes | 1993 |
Amelioration of chronic inflammation by ingestion of elemental diet in a rat model of granulomatous enteritis.
Topics: Amino Acids; Animals; Crohn Disease; Food, Formulated; Immunohistochemistry; Inflammation; Intestinal Mucosa; Male; Nitrates; Nitric Oxide Synthase; Nitrites; Peptidoglycan; Peyer's Patches; Rats; Rats, Wistar; Streptococcus pyogenes | 1997 |
Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis.
Topics: Animals; Chronic Disease; Crohn Disease; Cysteine Endopeptidases; Female; Gene Expression Regulation; Multienzyme Complexes; NF-kappa B; Nitric Oxide Synthase; Peptidoglycan; Proteasome Endopeptidase Complex; Rats; Rats, Inbred Lew; RNA, Messenger; Transcription, Genetic; Vascular Cell Adhesion Molecule-1 | 1997 |
Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach.
Topics: Adult; Aged; Bacteria; Cellulose; Chromatography, Gel; Crohn Disease; Feces; Food Additives; Humans; Middle Aged; Molecular Weight; Peptidoglycan; Statistics, Nonparametric; Viscosity | 1998 |
Involvement of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the pathogenesis of granulomatous colitis in rats.
Topics: Animals; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Cell Adhesion Molecules; Cell Movement; Chronic Disease; Crohn Disease; Endothelium, Vascular; Female; Immunoglobulins; Immunohistochemistry; Intestinal Mucosa; Mucoproteins; Peptidoglycan; Polysaccharides; Rats; Rats, Inbred Lew | 2001 |
Serum antibodies to peptidoglycan-polysaccharide complexes from the anaerobic intestinal flora in patients with Crohn's disease.
Topics: Antibodies, Bacterial; Bacteria, Anaerobic; Crohn Disease; Enzyme-Linked Immunosorbent Assay; Humans; Intestines; Peptidoglycan; Polysaccharides, Bacterial | 1990 |
Effect of a soluble bacterial carbohydrate fraction on the viscosity of intestinal contents in healthy subjects and patients with Crohn's disease.
Topics: Adult; Bacteria, Anaerobic; Chemical Precipitation; Chromatography, Gel; Crohn Disease; Feces; Humans; Middle Aged; Muramic Acids; Peptidoglycan; Sialic Acids; Viscosity | 1989 |